Total trials
358
Active
49
Phase 3
1
Total enrollment
45,032
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tranexamic Acid | — | — | — | — | — | 1 | |
| Combined Oral Contraceptive | — | — | — | — | — | 1 | |
| Dydrogesterone Pill | — | — | — | — | — | 1 | |
| Heart Failure drugs | — | — | — | — | — | 1 | |
| Storigami figure | — | — | — | — | — | 1 |
Next readouts
- 2025-08-20
- 2026-04-15
- 2026-06-01
- 2026-08-31
Top conditions
- Pain14
- Fear8
- Anxiety8
- Education7
- Nurse's Role7
- Virtual Reality6
- Multiple Sclerosis6
- Smoking5
Frequently asked questions about Ege University
- How many clinical trials does Ege University have on ClinicalTrials.gov?
- Ege University is listed as the lead sponsor on 358 clinical trials in ClinicalTrials.gov, 49 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ege University's trials are in Phase 3?
- 1 of Ege University's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Ege University focus on?
- Ege University's most-studied conditions on ClinicalTrials.gov are Pain, Fear, Anxiety, Education, Nurse's Role.
- When are Ege University's next clinical trial readouts?
- Ege University has 4 upcoming primary-completion readouts tracked here; the soonest is “The Effect of Storigami Method on Pain, Fear and Anxiety Levels Associated With Peripheral Intravenous Catheterisation in Children”, expected around 2025-08-20.